🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare a 2-dose and 3-dose series of...
Status
Recruiting
Location
University of Texas Medical Branch
Start Date
2023-01-18
Trial ID
NCT05672927
Treatments Being Tested
This is a phase 2, open-label study to assess the immunogenicity of the 9-v...
Status
Recruiting
Location
RIIS Clinic at HIPS
Start Date
2025-03-15
Trial ID
NCT06624839
Treatments Being Tested
A Study to evaluate if the 3 dose extended schedule (0-6-18 months) for the...
Status
Not Yet Recruiting
Location
Murdoch Children Research Institute
Start Date
2024-12-14
Trial ID
NCT06681636
Treatments Being Tested
A randomized, observer-blind non-inferiority trial to evaluate alternative ...
Status
Unknown
Location
Ed Clarke
Start Date
2019-09-14
Trial ID
NCT03832049
The purpose of this study was to evaluate the safety, efficacy, and immunog...
Status
Completed
Location
Multiple Locations
Start Date
2007-09-24
Trial ID
NCT00543543
Treatments Being Tested
Human papillomavirus (HPV) is the most common sexually transmitted infectio...
Status
Unknown
Location
BC Centre for Disease Control
Start Date
2022-09-01
Trial ID
NCT03947775
Treatments Being Tested
This study is an open-label nonrandomized exploratory proof of concept and ...
Status
Active Not Recruiting
Location
Boston Medical Center
Start Date
2022-09-26
Trial ID
NCT05329961
Treatments Being Tested
This phase IV trial compares 3 different dosing schedules to find the optim...
Status
Completed
Location
Evandro Chagas National Institute of Infectious Diseases (INI), Oswaldo Cruz Foundation (FIOCRUZ) STD and AIDS Clinical Research Laboratory
Start Date
2022-03-10
Trial ID
NCT04265950
Treatments Being Tested
Background: * Human papilloma virus (HPV) is a common sexually transmitted...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-06-29
Trial ID
NCT00798265
This study is designed to demonstrate non-inferior immunogenicity of 3 dose...
Status
Active Not Recruiting
Location
Liucheng County Centers for Disease Control and Prevention ( Site 0005)
Start Date
2022-05-07
Trial ID
NCT05314023
Treatments Being Tested